← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2009-04-03

Drug application

FDA Application #

ANDA090263

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell RX, LLC

First approval

2009-04-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown